Orla Protein Technologies Limited
Company profile
DissolvedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2019-02-28
IXBRL · 111 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2019-02-28
IXBRL · 111 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-02-28
- Extraction status
- Legacy / not assessed
- Numeric facts
- 55
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0074_04311436_20190228
- Source archive
- Accounts_Monthly_Data-January2020.zip
Registered details
04311436- Status
- Dissolved
- Type
- Unknown
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
9 matched grantsUsing ORLA PDL-1 to save the worldLead
Innovate UK · Feasibility Studies · 2017-04-01 – 2018-03-31
£69,348
awarded
Advanced protein coatings for biosensorsLead
Innovate UK · Feasibility Studies · 2015-06-01 – 2015-09-30
£23,100
awarded
SurfstemLead
Innovate UK · EU-Funded · 2013-10-01 – 2015-08-31
£93,687
awarded
Surfstem
EU · EU-Funded · 2013-09-30 – 2015-08-30
£93,687
whole project
SurfstemLead
EU · EU-Funded · 2013-09-30 – 2015-08-30
£93,687
whole project
Nano-bio enabled diagnostic devices for oral healthcareInnovate UK · Collaborative R&D · 2012-07-01 – 2015-06-30 · with 2 other participants£101,705awarded
Nano-bio enabled diagnostic devices for oral healthcare
Innovate UK · Collaborative R&D · 2012-07-01 – 2015-06-30 · with 2 other participants
£101,705
awarded
Orientedly immobilised proteins as next generation platforms for interferon gamma release assays for the diagnosis of Mycobacterium tuberculosiInnovate UK · Feasibility Studies · 2010-09-01 – 2011-08-31 · with 1 other participant£43,875awarded
Orientedly immobilised proteins as next generation platforms for interferon gamma release assays for the diagnosis of Mycobacterium tuberculosi
Innovate UK · Feasibility Studies · 2010-09-01 – 2011-08-31 · with 1 other participant
£43,875
awarded
Orla Protein Technologies Limited£43,875
GMP substrates for culture & derivation of clincal grade hESC cellsLeadInnovate UK · Feasibility Studies · 2010-07-01 – 2011-03-31 · with 2 other participants£65,000awarded
GMP substrates for culture & derivation of clincal grade hESC cellsLead
Innovate UK · Feasibility Studies · 2010-07-01 – 2011-03-31 · with 2 other participants
£65,000
awarded
Orla Protein Technologies Limitedlead£65,000
University of Newcastle£37,634
Health Protection Agency£35,000
VirasensLeadInnovate UK · Collaborative R&D · 2008-09-01 – 2012-02-29 · with 4 other participants£266,238awarded
VirasensLead
Innovate UK · Collaborative R&D · 2008-09-01 – 2012-02-29 · with 4 other participants
£266,238
awarded
Orla Protein Technologies Limitedlead£266,238
Health Protection Agency£0
University of Newcastle£0